Graf Industrial Corp. to Combine with Velodyne Lidar
by Kristi Marvin on 2020-07-02 at 12:47pm

This morning, Graf Industrial Corp. (GRAF) set the rumors to rest by announcing they have entered into an Agreement and Plan of Merger with Velodyne Lidar. As recently as April of 2020, Graf had been in “negotiations” to combine with a polypropylene recycling company, so the deal makers at Graf have been busy. The transaction will introduce Velodyne Lidar as a NYSE-listed public company with an anticipated initial enterprise value of approximately $1.6 billion, or 2.3x Velodyne’s estimated 2024 net company revenues.

For those unfamiliar with Velodyne, it is the pioneer of lidar technology and continues to be the market leader. Started in 2005, Velodyne has served over 300 customers throughout the world with their patented sensor products like the Puck™ and Ultra Puck™ and recent push into software through their Vella™ platform. As recently as 2017, the majority of revenues came from autonomous vehicle applications. Today, autonomous vehicles make up closer to 25% of total revenues, with Advanced Driver Assistance Systems (ADAS), Robotics and Industrial, Mapping, Shuttles, Smart City, and Delivery making up a larger portions of the total company revenues.

Velodyne’s business does not have a great set of public comps since it would be the only pure-play public lidar company, but comparisons can be made by looking at companies that operate in Velodyne’s three core categories: Computing Platforms (NVDA, XLNX), Vision Based Software-Rich Solutions (AMBA), and Disruptive Auto-Tech Players (TSLA, NKLA). Velodyne’s competitive advantages or “moats” include customer entrenchment, an extensive patent portfolio, a broad product offering and commercial scale manufacturing capabilities.

Autonomous vehicle technology has seen dramatic growth the last decade and is projected to increase by ~18% CAGR from 2020-2025. Over $50 billion has been invested in autonomous technology in the past 5 years, with 70% of this investment coming outside the auto industry. Lidar is one of the critical technologies enabling this growth. David Hall, founder and executive chairman of Velodyne, says, “Lidar technology is mandatory for machines to perceive the world and make safe decisions. Velodyne has the key technology that is enabling the age of autonomous machines.” As a market leader, Velodyne is in a strong position to ride this wave of growth.

As far as the official “details” of this transaction, at the closing, existing Velodyne shareholders will receive up to approximately 83% of the newly issued shares of the Company and $50 million in cash. In addition, Velodyne will issue two million additional shares to existing Velodyne shareholders after closing of the transaction if the common stock of the combined company on the NYSE is at least $15.00 for 20 days of any 30-day period from the date hereof through the date that is six months after the closing of the merger. Velodyne is expected to add approximately $190 million of cash to its balance sheet to fund growth initiatives.


Quick Take: Velodyne has patented tech, an accomplished founder and CEO, existing customers, a growing software platform, and 15 years of business history, all catering to an industry that is projected to grow at a CAGR of ~18% for the next five years. The negative cash flow from operations for 2017 through 2019 could be a concern, but investors are willing to pay up for technology based growth stories right now, especially in auto. The large equity rollover looks good by ensuring management incentive’s are aligned with investors and the TEV/Revenue multiple is reasonable relative to peers, assuming Velodyne’s revenue projections for 2024 are anywhere close to actual.


ADVISORS

  • BofA Securities is acting as exclusive financial advisor to Velodyne.
  • Oppenheimer & Co. Inc. is acting as financial advisor and PIPE private placement agent to GRAF.
  • Oppenheimer & Co. Inc. and EarlyBirdCapital, Inc. are acting as capital markets advisors to GRAF.
  • Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is acting as legal advisor to Velodyne
  • White & Case LLP is acting as legal advisor to GRAF.

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved